Apogee Therapeutics, Inc. Common Stock (APGE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $69.09
• Market Cap: $4.84B
• EPS: $-4.38
• 52-Week High: $84.56
• 52-Week Low: $26.20

Market Sentiment

Apogee Therapeutics, Inc. Common Stock currently has a Bullish sentiment score of 0.39.

About Apogee Therapeutics, Inc. Common Stock

Apogee Therapeutics, Inc. is a pioneering biotechnology firm headquartered in Waltham, Massachusetts, dedicated to advancing biologic therapies for chronic inflammatory disorders, such as atopic dermatitis and chronic obstructive pulmonary disease (COPD). With a strong emphasis on innovative science and a promising pipeline, the company aims to fulfill critical unmet medical needs in immunology, thereby enhancing patient outcomes. As Apogee continues to evolve in the biopharmaceutical landsca...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Apogee Therapeutics, Inc. Common Stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does APGE pay dividends?

Apogee Therapeutics, Inc. Common Stock (APGE) does not currently pay a regular dividend.

What is APGE's market cap?

Apogee Therapeutics, Inc. Common Stock (APGE) has a market capitalization of $4.84B with a current stock price of $69.09.